Despite medical innovations, maternal mortality rates in the US remain high, especially compared with those of similarly ...

Patients with acute episodic migraine consistently prioritize pain relief over other treatment attributes such as route of administration, adverse outcomes, and costs, according to study results ...

The FDA has approved Atzumi (dihydroergotamine) nasal powder for the acute treatment of migraine with or without aura in adults.

For patients with overweight or obesity and symptomatic knee OA, metformin is associated with a greater improvement in knee pain than placebo.

Denosumab plus romosozumab vs denosumab only was associated with improved bone mineral density among patients with severe postmenopausal osteoporosis.

Patients with psoriatic arthritis have delays in diagnosis compared with those with rheumatoid arthritis, according to study findings.

Declining childhood vaccination rates may increase outbreaks of eliminated vaccine-preventable infections within the US, leading to a return to endemicity.

US Health and Human Services Secretary Robert F. Kennedy Jr is preparing to launch a multimillion-dollar public health campaign.

The FDA has granted marketing authorization to CT-132 for the preventive treatment of episodic migraine in patients aged 18 years and older.

Oral opioid use is common among patients with SPRA, ankylosing spondylitis, and PsA and is associated with an increased risk of mortality.

Among patients with acute LBP, use of nonpharmacologic therapy was associated with reduced risk for overdose-related hospitalizations.

Families of children with disabilities have a nearly doubled likelihood of experiencing financial hardships vs families of children without disabilities.